MENU
IMTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Immatics (IMTX) Ownership - Who owns Immatics?

Profile

Industry
N/A
Address
Paul-Ehrlich-Strasse 15
Phone
+49 707153970
Employees
343
Web
https://www.immatics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.21B
P/E Ratio
N/A
Total Cash
531.11M
Projected Growth
N/A
Total Debt
17.41M
Revenue
70.87M
Risk (Beta)
1.30
Dividend Yield
N/A
Total Cash/Share
5.15
Total Debt/Equity
N/A
Revenue/Share
0.86 USD as % of share price

Fundamentals

IMTX
Capitalization
1.21B
P/E Ratio
N/A
Risk (Beta)
1.30
Dividend Yield
N/A
Total Cash
531M
Total Cash/Share
5.15
Total Debt
17.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.86%
Revenue
70.9M
ROE
N/A
Book Value
388M
P/B Ratio
2.72
Cash Flow
N/A
Earnings
-0.83
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.03M
Current Ratio
3.74
Current Revenue Per Employee
54679.30
Dividends Per Share - Security
N/A
EBITDA
-61.68M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-14.21
Shares Held By Institutions
1.01B
Shares Outstanding - Current
103M
Total Liabilities
239M
Total Volume MTD
N/A
Value
N/A
Gain YTD
3.134
View a ticker or compare two or three
IMTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Paul-Ehrlich-Strasse 15
Phone
+49 707153970
Employees
343
Web
https://www.immatics.com